Andrew M Scott

Loading... 2 0 20 0 false
Credit Name
Andrew M Scott
Full Name
Scott, Andrew M
 
Title
Prof
 
264-Scott.jpg picture
 
Personal Site
https://www.onjcancercentre.org/
 
Twitter
Biography
We love promoting your work, however you know best what to say. Please login and update your profile or let us know what you would like to say about yourself!
 
Loading... 3 0 20 0 false

Publications

Results 21-40 of 271 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
2120-Dec-2022Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.Lopci, E; Aide, N; Dimitrakopoulou-Strauss, A; Dercle, L; Iravani, A; Seban, R D; Sachpekidis, C; Humbert, O; Gheysens, O; Glaudemans, A W J M; Weber, W A; Van den Abbeele, A D; Wahl, R L; Scott, Andrew M ; Pandit-Taskar, N; Hicks, R J
2218-Nov-2022ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian; Akhurst, Tim; Roselt, Peter; Trinh, Jenny; John, Thomas ; Devereux, Lisa; Donnelly, Paul S; Hicks, Rod; Scott, Andrew M ; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun ; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacManus, Michael
2310-Nov-2022Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy.Cao, Zhipeng; Burvenich, Ingrid J; Zhao, Kening; Senko, Clare ; Glab, Jason; Fogliaro, Renee; Liu, Zhanqi; Jose, Irvin; Puthalakath, Hamsa; Hoogenraad, Nick J; Osellame, Laura D; Scott, Andrew M 
24Nov-2022PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.Buteau, James P; Martin, Andrew J; Emmett, Louise; Iravani, Amir; Sandhu, Shahneen; Joshua, Anthony M; Francis, Roslyn J; Zhang, Alison Y; Scott, Andrew M ; Lee, Sze Ting ; Azad, Arun A; McJannett, Margaret M; Stockler, Martin R; Williams, Scott G; Davis, Ian D; Hofman, Michael S
256-Aug-2022The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.Kiamanesh, Zahra; Ayati, Narjess ; Sadeghi, Ramin; Hawkes, Eliza A ; Lee, Sze Ting ; Scott, Andrew M 
26Aug-2022Radiotheranostics in oncology: current challenges and emerging opportunities.Bodei, Lisa; Herrmann, Ken; Schöder, Heiko; Scott, Andrew M ; Lewis, Jason S
27Aug-2022A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.Gan, Hui K ; Parakh, Sagun ; Lee, Fook-Thean; Tebbutt, Niall C ; Ameratunga, Malaka; Lee, Sze Ting ; O'Keefe, Graeme J; Gong, Sylvia J; Vanrenen, Christine; Caine, Jaren; Giovannetti, Mara; Murone, Carmel ; Scott, Fiona E; Guo, Nancy; Burvenich, Ingrid J G; Paine, Cameron; Macri, Mary J; Kotsuma, Masakatsu; Senaldi, Giorgio; Venhaus, Ralph; Scott, Andrew M 
2828-Jun-2022Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours.Yan, Hengkang; Vail, Mary E; Hii, Linda; Guo, Nancy; McMurrick, Paul J; Oliva, Karen; Wilkins, Simon; Saha, Nayanendu; Nikolov, Dimitar B; Lee, Fook-Thean; Scott, Andrew M ; Janes, Peter W 
2921-Jun-202218F Site-Specific Labelling of a Single-Chain Antibody against Activated Platelets for the Detection of Acute Thrombosis in Positron Emission Tomography.Ardipradja, Katie S; Wichmann, Christian W; Hickson, Kevin; Rigopoulos, Angela; Alt, Karen M; Pearce, Hannah A; Wang, Xiaowei; O'Keefe, Graeme; Scott, Andrew M ; Peter, Karlheinz; Hagemeyer, Christoph E; Ackermann, Uwe 
30Jun-2022The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective.Lee, Sze Ting ; Emmett, Louise M; Pattison, David A; Hofman, Michael S; Bailey, Dale L; Latter, Melissa J; Francis, Roslyn J; Scott, Andrew M 
314-Apr-2022Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.Lopci, E; Hicks, R J; Dimitrakopoulou-Strauss, A; Dercle, L; Iravani, A; Seban, R D; Sachpekidis, C; Humbert, O; Gheysens, O; Glaudemans, A W J M; Weber, W; Wahl, R L; Scott, Andrew M ; Pandit-Taskar, N; Aide, N
3211-Mar-2022Radiolabeled Antibodies for Cancer Imaging and Therapy.Parakh, Sagun ; Lee, Sze Ting ; Gan, Hui K ; Scott, Andrew M 
33Mar-2022Automated processing of solid target 86Y using enriched SrO powder.Dinh, Thien; Panopoulos, Harris; Poniger, Stan ; Scott, Andrew M 
34Feb-2022Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT.McKay, Michael J; Taubman, Kim L; Lee, Sze Ting ; Scott, Andrew M 
3524-Jan-2022VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K ; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S ; Weickhardt, Andrew J ; Wilson, Kate; Scott, Andrew M ; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C 
3615-Jan-2022Single-Cell Transcriptomics Reveals Discrete Steps in Regulatory T Cell Development in the Human Thymus.Morgana, Florencia; Opstelten, Rianne; Slot, Manon C; Scott, Andrew M ; van Lier, René A W; Blom, Bianca; Mahfouz, Ahmed; Amsen, Derk
372022Antibody-drug conjugates: beyond current approvals and potential future strategies.Menon, Siddharth; Parakh, Sagun ; Scott, Andrew M ; Gan, Hui K 
382022Impact of 18F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative 131I whole body scan and elevated serum thyroglobulin.Boktor, Raef R; Lee, Sze Ting ; Berlangieri, Salvatore U ; Scott, Andrew M 
392022Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition.Daly, Roger J; Scott, Andrew M ; Klein, Oliver ; Ernst, Matthias 
402022Monte Carlo calculated calibration settings for commercially available nuclear medicine ionisation chambers.Pain, Cameron Dennis; O'Keefe, Graeme J; Scott, Andrew M